Sarepta Therapeutics Inc. (SRPT)
NasdaqGS: SRPT
· Real-Time Price · USD
18.05
-0.13 (-0.72%)
At close: Aug 18, 2026, 10:53 AM
Sarepta Therapeutics Inc. (SRPT) Stock Price, Analysis & Data
-0.72% (1D)
| Bid | 12.99 |
| Market Cap | 1.91B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | 7.02 |
| P/B (ttm) | 1.25 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 4, 2026 |
| Ask | 22.82 |
| Volume | 167,254 |
| Avg. Volume (20D) | 3,277,862 |
| Open | 18.17 |
| Previous Close | 18.18 |
| Day's Range | 18.01 - 18.29 |
| 52-Week Range | 14.68 - 25.32 |
| Analyst | Hold |
| Price Target | 20 (10.80%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SRPT
A detailed description of the company is not yet available....
Industry n/a
Sector n/a
IPO Date Jun 4, 1997
Employees n/a
Stock Exchange NasdaqGS
Ticker Symbol SRPT
Financial Performance
In 2025, Sarepta Therapeutics's revenue was 2.2B, an increase of 15.58% compared to the previous year's 1.9B. Earnings were -713.41M, a decrease of -403.27%.
Financial StatementsAnalyst Forecast
According to 23 analyst ratings, the average rating for SRPT stock is "Hold". The 12-month stock price forecast is 20, which is upside of 10.8% from the latest price.
Stock ForecastsEarnings Surprise
Sarepta Therapeutics has released their quarterly earnings on Aug 5, 2026:
Sarepta Therapeutics Inc. is scheduled to release its earnings on Nov 4, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2